(1)
Guth, M. A. The Highest Clinical Trial Failure Rate for Any Disease in Modern Medicine: How Both Amyloid- and Non-Amyloid-Targeting Therapies Failed to Alter Disease Course in Alzheimer’s Disease. FreeNeuropathol 2026, 7, 22.